SGRX SANGRIX INC. Annual reports only
Finance Services · Nasdaq · SEC CIK 1735556 · Fiscal year ends 06/30
Financial factors as of 2025-06-30 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY2026*2026-06-30 | FY2025*2025-06-30 | FY20242024-06-30 | FY20232023-06-30 | FY20222022-06-30 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | — | $39,495 | $2.89M | $6.26M | $192,351 |
| Cost of revenue | — | — | $3.83M | $10.83M | $10.83M |
| Gross profit | — | $39,495 | -$945,202 | -$4.57M | -$4.57M |
| SG&A expense | $2.75M | $3.08M | $3.82M | $2.91M | $2.91M |
| Operating income | -$14.28M | -$2.99M | -$14.84M | -$28.30M | -$28.30M |
| Interest expense | — | $665,194 | $595,685 | $36,380 | $227,376 |
| Pretax income | -$14.29M | -$4.37M | -$18.28M | -$28.22M | -$28.22M |
| Net income | -$14.29M | -$4.39M | -$17.53M | -$28.22M | $3.24M |
| EBITDA | — | -$2.99M | -$13.93M | -$22.94M | — |
| EPS (basic) | -70.43 | -84.84 | -1,003.41 | — | -8.61 |
| EPS (diluted) | -70.43 | -84.84 | -1,003.41 | — | -8.61 |
| Weighted avg. shares (diluted) | 339,699 | 77,016 | 17,472 | 3.28M | 3.28M |
| Banking | |||||
| Loans, net | $13.42M | $1.89M | — | — | — |
| Balance sheet | |||||
| Cash & equivalents | $1.57M | $55,639 | $1.41M | $16,274 | $17,805 |
| Receivables | — | — | $117,000 | $0 | $0 |
| Current assets | $10.17M | $3.54M | $6.68M | $3.57M | $23.93M |
| PP&E, net | — | — | — | $7.37M | $8.03M |
| Total assets | $21.16M | $3.54M | $6.68M | $13.34M | $34.95M |
| Current liabilities | $1.46M | $372,083 | $2.49M | $2.59M | $299,968 |
| Total liabilities | $12.08M | $372,083 | $5.78M | $3.07M | $299,968 |
| Shareholders' equity | $5.62M | $3.90M | $1.66M | $10.26M | $34.65M |
| Shares outstanding | — | 970,185 | 7.76M | 3.38M | 3.06M |
| Cash flow statement | |||||
| Operating cash flow | -$2.92M | -$2.29M | -$7.93M | -$6.76M | -$14.24M |
| Capital expenditure | — | — | — | $115,033 | $8.30M |
| Free cash flow | — | — | — | -$6.88M | -$22.54M |
| Investing cash flow | -$200,000 | $1.55M | $1.02M | $4.27M | -$11.31M |
| Financing cash flow | $4.64M | -$608,712 | $8.30M | $2.49M | $25.94M |
| Depreciation & amortization | — | $0 | $900,938 | $5.36M | — |
| Stock-based compensation | — | — | $73,230 | $67,271 | $67,271 |
Free plan shows the latest 5 periods; Pro shows all 10 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.